Bicara Therapeutics Inc. ...
12.90
0.06 (0.51%)
At close: Jan 15, 2025, 1:24 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22
Net Income -51.98M -37.84M
Depreciation & Amortization 19.00K 10.00K
Stock-Based Compensation 1.90M 810.00K
Other Working Capital -9.62M 4.95M
Other Non-Cash Items 14.06M n/a
Deferred Income Tax n/a n/a
Change in Working Capital -9.62M 4.95M
Operating Cash Flow -45.63M -32.08M
Capital Expenditures -586.00K -192.00K
Acquisitions n/a n/a
Purchase of Investments n/a n/a
Sales Maturities Of Investments n/a n/a
Other Investing Acitivies n/a n/a
Investing Cash Flow -586.00K -192.00K
Debt Repayment n/a n/a
Common Stock Repurchased n/a n/a
Dividend Paid n/a n/a
Other Financial Acitivies 272.35M 31.54M
Financial Cash Flow 272.50M 31.70M
Net Cash Flow 226.28M -573.00K
Free Cash Flow -46.21M -32.27M